Studying neurodegenerative diseases in culture models. (Q38165760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

1 March 2020

title

Studying neurodegenerative diseases in culture models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Antonio Carlos Pinheiro de Oliveira

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

Brazilian Journal of Psychiatry

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

1 March 2020

volume

35 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

S92-100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24271231 AND SRC:MED&resulttype=core&format=json

Axon degeneration in Parkinson's disease

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The many faces of α-synuclein: from structure and toxicity to therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

What genetics tells us about the causes and mechanisms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Update on the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Derivation of dopaminergic neurons from pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Midbrain dopaminergic neurons are protected from radical induced damage by GDF-5 application. Short communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

JNK isoforms differentially regulate neurite growth and regeneration in dopaminergic neurons in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Synaptic currents and transmitter responses in human NT2 neurons differentiated in aggregate culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Exosomal cell-to-cell transmission of alpha synuclein oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The neuropsychological profile of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuropathological alterations in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglial activation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

21 January 2018

Physiology of microglia

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Comparison of prostanoid forming capacity of neuronal and astroglial cells in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E2 production in activated rat microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Amyloid beta peptide (25-35) activates protein kinase C leading to cyclooxygenase-2 induction and prostaglandin E2 release in primary midbrain astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglial degeneration in the aging brain--bad news for neurons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Isolation of murine microglial cells for RNA analysis or flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Efficient isolation of live microglia with preserved phenotypes from adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Microglial cells in astroglial cultures: a cautionary note

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The mystery and magic of glia: a perspective on their roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Functions of mature mammalian astrocytes: a current view

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The problem of astrocyte identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Interleukin-1 beta-induced expression of the prostaglandin E-receptor subtype EP3 in U373 astrocytoma cells depends on protein kinase C and nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neurodegenerative processes in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The influence of huntingtin protein size on nuclear localization and cellular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Gastrodia elata prevents huntingtin aggregations through activation of the adenosine A₂A receptor and ubiquitin proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

POTENTIAL APPLICATION OF GRAPE DERIVED POLYPHENOLS IN HUNTINGTON'S DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Pro-apoptotic protein kinase C delta is associated with intranuclear inclusions in a transgenic model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Generation and characterization of embryonic striatal conditionally immortalized ST14A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

ST14A cells have properties of a medium-size spiny neuron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

A two-step path to inclusion formation of huntingtin peptides revealed by number and brightness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Isolation and characterization of the rat huntingtin promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

A cellular model that recapitulates major pathogenic steps of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Transcriptional activation of REST by Sp1 in Huntington's disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Activation of MLK2-mediated signaling cascades by polyglutamine-expanded huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Induction of apoptosis in cells expressing exogenous Hippi, a molecular partner of huntingtin-interacting protein Hip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Amyotrophic lateral sclerosis model derived from human embryonic stem cells overexpressing mutant superoxide dismutase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590/1516-4446-2013-1159